| 000 | 02250cam a2200301 4500500 | ||
|---|---|---|---|
| 005 | 20250121162527.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aBalestrini, Simona _eauthor |
| 700 | 1 | 0 |
_a Arzimanoglou, Alexis _eauthor |
| 700 | 1 | 0 |
_a Blümcke, Ingmar _eauthor |
| 700 | 1 | 0 |
_a Scheffer, Ingrid E. _eauthor |
| 700 | 1 | 0 |
_a Wiebe, Samuel _eauthor |
| 700 | 1 | 0 |
_a Zelano, Johan _eauthor |
| 700 | 1 | 0 |
_a Walker, Matthew C. _eauthor |
| 245 | 0 | 0 | _aThe aetiologies of epilepsy |
| 260 | _c2021. | ||
| 500 | _a89 | ||
| 520 | _aThe identification of the aetiology of a patient's epilepsy is instrumental in the diagnosis, prognostic counselling and management of the epilepsies. Indeed, the aetiology can be important for determining the recurrence risk of single seizures and so for making a diagnosis of epilepsy. Here, we divide the aetiologies into six categories: structural, genetic, infectious, metabolic, immune (all of which are part of the International League Against Epilepsy [ILAE] classification system) and neurodegenerative (which we have considered separately because of its growing importance in epilepsy). These are not mutually exclusive categories and many aetiologies fall into more than one category. Indeed, genetic factors probably play a role, to varying degrees, in the risk of seizures in all people with epilepsy. In each of the categories, we discuss what we regard as the most important aetiologies; importance being determined not only by prevalence but also by clinical significance. The introduction contains information suitable for level 1 competency (entry level), whilst the subsequent sections contain information aimed at level 2 competency (proficiency level) as part of the new ILAE competency-based curriculum. As we move towards precision medicine and targeted therapies, so aetiologies will play an even greater role in the management of epilepsy. | ||
| 690 | _agenetic | ||
| 690 | _aimmune | ||
| 690 | _astructural | ||
| 690 | _ainfectious | ||
| 690 | _ametabolic | ||
| 690 | _aneurodegenerative | ||
| 786 | 0 | _nEpileptic Disorders | Vol 23 | 1 | 2021-01-01 | p. 1-16 | 1294-9361 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/revue-epileptic-disorders-2021-1-page-1?lang=en&redirect-ssocas=7080 |
| 999 |
_c611452 _d611452 |
||